Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00793182 · ClinicalTrials.gov registry record · Phase 4
Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography
A Phase 4 study, sponsored by Guerbet.
- Terminated
- Registry status
- Phase 4
- Development phase
- 6
- Enrollment target
NCT00793182: Clinical Trial Phase 4 study, sponsored by Guerbet.
NCT00793182 is a Phase 4 study that was terminated before completion, run by Guerbet. The registered enrollment target is 6 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00793182, a Phase 4 study, was terminated before completion, sponsored by Guerbet.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the contrast-induced nephropathy (CIN) rate in subjects randomized to receive either Ioversol or Iodixanol for contrast-enhanced computed tomography.
Primary Outcome
Contrast-induced nephropathy (CIN) is defined as an increase of ≥ 25% or an increase of ≥ 0.5 mg/dL from baseline serum creatinine (SCr), within 48 - 72 hours after contrast medium administration. For each patient, SCr values were measured from 2 to 24 hours before and from 48 to 72 hours after contrast medium administration.
Interventions
- DRUG Ioversol 320 mgI/mL
- DRUG Iodixanol 320 mgI/mL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-06 |
| Phase | Phase 4 |
Why NCT00793182 stopped before completion
NCT00793182 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Ioversol 320 mgI/mL is the first listed.
NCT00793182 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00793182 about?
NCT00793182 is a clinical study titled "Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography". The purpose of this study is to evaluate the contrast-induced nephropathy (CIN) rate in subjects randomized to receive either Ioversol or Iodixanol for contrast-enhanced computed tomography.
What is the current status of trial NCT00793182?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 6 participants. The study started on 2009-01. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00793182?
The interventions under investigation include: Ioversol 320 mgI/mL (DRUG), Iodixanol 320 mgI/mL (DRUG).
Who is sponsoring clinical trial NCT00793182?
This trial is sponsored by Guerbet, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00793182's enrollment target sits among peer trials
6 1983rd of 2000 higher than 12 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia